Bifidobacterium bifidum
 For the course duration, the article is closed to outside editing. Of course you can always leave comments on the discussion page. The anticipated date of course completion is May 21, 2009. One month after that date at the latest, this notice shall be removed. Besides, many other Citizendium articles welcome your collaboration! |
| Scientific classification | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
| Binomial name | ||||||||||||||
Description and significance
Bifidobacteria are included in a subsection of bacteria known as probiotics. Probiotics are a natural occurrence in the human body, contributing to the beneficial micro flora in the mouth, intestinal tract, as well as vagina. Bifidobacteria are attributed with a vast array of beneficial physiologic effects which include: digestion promotion, augmentation of the immune system, contribution to the production of lactic and acetic acid, lower serum cholesterol levels, and in some cases are associated with a lower incidence of allergies as well as the promotion of calcium absorption and the synthesis of B-complex vitamins. In addition, bifidobacteria have been utilized as home remedies for diarrhea, vaginitis, yeast infections, as well as irritable bowel syndrome.
*Please note that modification of this section is still in progress.
Genome structure
Bifidobacterium bifidum has a circular chromosome with a G-C content of approximately 55-67%. Bifidobacterial species' genomes range in size from 1.9 to 2.9 Mb. Their number of rRNA operons also varies between one and five. Although a number of bifidobacterial plasmids have been sequenced, all but one, NCFB 1454, from B. bifidum, are not known to encode for a phenotypic trait. It is believed that NCFB 1454 encodes bacteriocin bifidocin B.[Ventura] Bacteriocins are antibiotic substances produced by one bacteria that inhibit the growth and metabolic activity of closely related species. [1]
The following links to The National Center for Biotechnology Information (NCBI) are only some of the genetic sequences available from a vast number of bifidobacterium bifidum genes and plasmids.
Bifidobacterium bifidum pB80 plasmid
Bifidobacterium bifidum alpha-galactosidase (melA) gene
Bifidobacterium bifidum pyrF, pyrK, pyrDb, pyrE genes
Bifidobacterium bifidum NCIMB 41171 beta-galactosidase Bbg1 gene
Bifidobacterium bifidum JCM 1254 lacto-N-biosidase (lnbB) gene
Bifidobacterium bifidum gene for 16S ribosomal RNA
*Please note that modification of this section is still in progress.
Cell structure and metabolism
Bifidobacteria are Gram-positive, anaerobic, and nonmotile. The characteristic rod or clubbed shape of Bifidobacterium bifidum varies from 0.5-1.3 μm x 1.5-8 μm. They can be found either living independently or associated in clusters and V-shaped pairs. These bacteria are commonly found curved and in a branched confirmation. Bifidobacteria are a part of a group of beneficial bacteria that are found in fermented dairy products, most commonly yogurt.
*Please note that modification of this section is still in progress.
Ecology
Bifidobacteria constitute approximately 90% of the microbiota found in the intestines of breast-fed infants. The specific breakdown by species varies but the major contributors include: B. brevi, B. longum, B. pseudocatenulatum, B. adolescentis, B. pseudolongum, and B. bifium. The number of bifidobacteria in the fecal flora of adults, however, is much lower around 3-6%. Numerous studies have been conducted that illustrate a variance of gut microbiota with subject age.
*Please note that modification of this section is still in progress.
Economic Importance
The numerous beneficial attributes of bifidobacteria have led to the increased awareness and publicity of probiotics, especially in the form of yogurt products. Bifidobacteria have also become available to consumers in the form of capsule supplements as well as enriched baby formula.
*Please note that modification of this section is still in progress.
Current Research
Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity- a randomized, double-blind, placebo-controlled study.
The effects of prebiotics such as galactooligosaccharides (GOS) and long-chain fructooligosaccharides (lcFOS) that encourage the proliferation of bifidobacteria were examined on maternal gut microbiota during the third trimester of pregnancy and following delivery. This study aimed to determine whether maternal microbiota is passed to newborns via breast-feeding, and, as a secondary outcome, whether maternal gut microbiota affects the fetal immune response. It is known that early infant gut microbiota influence an individual’s susceptibility to developing allergies later in life, although the exact reason and mechanism are unknown. The quantity of bifidobacteria and lactobacilli from the excised population was determined by fluorescent in situ hybridization and quantitative polymerase chain reaction in maternal and infant stool samples. The second objective, to examine the fetal immune response, utilized samples of cord blood by using flow cytometry and cytokine multiplex-array analysis. The results of this study relay that although GOS/lcFOS supplementation during pregnancy has a bifidogenic effect on maternal intestine micro flora, it is not passed on to newborns. Furthermore, there was no correlation between increased maternal bifidobacteria and enhanced fetal immune response.
Exploring the diversity of the bifidobacterial population in the human intestinal tract.
While the beneficial aspects of bifidobacteria are widely accepted, the diversity and specific composition of the human intestine micro flora are less understood. Researchers conducted this study to identify specific bifidobacterial populations found in human intestines and fecal samples. Their protocol included plating human intestinal mucosal and fecal samples on selective media and further analyzing molecular data of selected rRNA gene sequences of individual colonies. Their findings clearly indicated that the majority, 704 of the 900 isolated colonies, were bifidobacteria. They further identified the six major species of bifidobacteria isolated from the intestine: B. longum, B. pseudocatenulatum, B. adolescentis, B. pseudolongum, B. breve, and B. bifidum, and two species found primarily in fecal samples, B. dentium and B. animalis subp. lactis. Their research indicated a correlation between age and the microbiota distribution of the intestine. A small selection of species were found exclusively in the adult human gut, while other species were found widely distributed. The study uncovered significant variance between individuals in the composition of fecal samples and intestinal mucosal samples as well as mild variance within the same subject (intrasubject variability) in different regions of the intestine. There were a small number of bifidobacteria that indicated the capacity to broadly colonize, which was based on the number that were able to be isolated from wide ecological distributions.
Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR.
*Please note that modification of this section is still in progress.
References
http://en.wikipedia.org/wiki/Bacteriocin
http://microbewiki.kenyon.edu/index.php/Bifidobacterium
*Please note that modification of this section is still in progress.